Thermo Fisher Scientific Launches Applied Biosystems QuantStudio Absolute Q Digital PCR System
the first integrated digital PCR solution ideal for oncology, cell and gene therapy development and other research applications
Read MoreMedTech Industry Dynamics
MedTech Industry Dynamics
the first integrated digital PCR solution ideal for oncology, cell and gene therapy development and other research applications
Read MoreNew capacity will help U.S. customers meet current and future demand surges for vital laboratory plastics
Read MoreEarlier collaboration, starting with a multiyear, global agreement, may speed development and introduction of targeted precision medicine therapies for patients
Read MoreThermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic
Read MoreTo monitor and validate COVID-19 molecular diagnostic tests
Read MoreThe transaction values QIAGEN at approximately $11.5 billion at current exchange rates, which includes the assumption of approximately $1.4 billion of net debt.
Read More